Heartware Limited


View in Other Languages


Heartware Announce Clinical Trial Update

🕔7/13/2007 1:46:04 PM 4268

Following significant shareholder enquiry, the Company provides an update of the status of the international clinical trial currently underway for HeartWare's (ASX: HTW) HVAD TM Left Ventricular Assist Device.

Read Full Article

Heartware Delivers Australian Presentation on HVAD Implants

🕔6/15/2006 2:42:46 PM 4273

With reference to the clinical trial currently underway for HeartWare's (ASX: HTW) HVAD left ventricular assist device, Mr McConchie commented:

Read Full Article

HEARTWARE LIMITED ASX: HTW - Introduction to Heartware - Mr Howard Leibman, Director of Corporate development

🕔5/29/2006 2:30:00 PM 4118

HEARTWARE LIMITED (ASX: HTW) - Introduction to Heartware - Mr Howard Leibman, Director of Corporate development; Boardroomradio is pleased to announce that HEARTWARE LIMITED (ASX: HTW) has published a

Read Full Article

Heartware Annual General Meeting Presentation May 23, 2006

🕔5/23/2006 10:03:08 AM 4244

HeartWare (ASX: HTW) in accordance with ASX Listing Rule 3.13.3 provides a copy of the presentations which are to be delivered today at the Company's Annual General Meeting.

Read Full Article

HeartWare Receives Regulatory Approval For HVAD Implants in the UK

🕔5/22/2006 11:18:26 AM 4506

HeartWare (ASX: HTW) is pleased to announce that it has received regulatory approval from the Medicines and Healthcare Products Regulatory Agency ("MHRA") to commence implants of its HVAD circulatory assist device in the United Kingdom.

Read Full Article

HeartWare Ltd Offers Shareholders Discounted Shares on ASX

🕔5/19/2006 1:04:56 PM 4330

HeartWare Limited (ASX: HTW) announced to shareholders the Share Purchase Plan dated 19 May 2006 (Plan). The Plan allows shareholders to purchase up to A$5,000 worth of ordinary shares in HeartWare Limited (Heartware or the Company) at A$1.10 per share, which is an issue price discounted to the market price of HeartWare shares on the Australian Stock Exchange (ASX) and free of brokerage or transaction costs.

Read Full Article

HeartWare Announce $32.5 Million Capital Raising

🕔5/10/2006 4:08:15 PM 3260

HeartWare Limited (ASX: HTW) is pleased to announce that it has received commitments for $32.5 million from institutional and sophisticated investors in Australia and the United States.

Read Full Article

HeartWare Appoints COO to Florida Operations Centre

🕔4/21/2006 12:14:45 PM 3697

HeartWare is pleased to announce the appointment of Mr Dozier Rowe as Chief Operating Officer, based at HeartWare's operations centre in Miramar, Florida.

Read Full Article

First Human Implant of HeartWare's HVAD

🕔3/24/2006 7:19:28 PM 3974

On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.

Read Full Article

Heartware Gets Regulatory Approval in Europe for Human Implants

🕔1/5/2006 10:26:28 AM 3336

HeartWare is pleased to announce the receipt of its first regulatory approval to commence human implants of the HVAD left ventricular assist device. Approval was received from the Austrian Ministry of Health.

Read Full Article


  • This Page Viewed: (Last 7 Days: 26) (Last 30 Days: 144) (Since Published: 12141) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Listed
  • 31 Jan 2005